Snowball logo
logo
3239

Vaxcell-Bio Therapeutics Co. Ltd

323990 • KQ
₩4,015.00+₩45.00  (1.13%)
Estimate
Beta
3.721
Growth
Revenue, YoY
-18.19%
Net income, YoY
-5.87%
FCF, YoY
-6.53%
About the company
Ticker
323990
ISIN
Country
South Korea
Sector (GICS)
Healthcare
Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.

Frequently asked questions

What sector does Vaxcell-Bio Therapeutics Co. Ltd (323990) operate in?

Vaxcell-Bio Therapeutics Co. Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Vaxcell-Bio Therapeutics Co. Ltd (323990) current stock price?

As of the latest data, Vaxcell-Bio Therapeutics Co. Ltd stock price is ₩4,015, with a previous close of ₩3,970. Vaxcell-Bio Therapeutics Co. Ltd gained ₩45 in the last trading session, representing a 1.13% increase.

What is Vaxcell-Bio Therapeutics Co. Ltd (323990) current market capitalization?

Vaxcell-Bio Therapeutics Co. Ltd market cap is approximately 93.04 billion.

What is Vaxcell-Bio Therapeutics Co. Ltd (323990) EBITDA?

Vaxcell-Bio Therapeutics Co. Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.36 billion.

Does Vaxcell-Bio Therapeutics Co. Ltd (323990) pay dividends?

No. Vaxcell-Bio Therapeutics Co. Ltd does not pay a dividend.

What is Vaxcell-Bio Therapeutics Co. Ltd (323990) beta (volatility) score?

Vaxcell-Bio Therapeutics Co. Ltd has a beta of 3.721, indicating very high volatility compared to the market.